logo-loader
RNS
Elementis plc

Elementis PLC - Sale of Pharma business & intended buyback launch

RNS Number : 5432G
Elementis PLC
02 June 2026
 

2 June 2026

 

Elementis plc

 

Completion of sale of pharmaceutical manufacturing business

Launch of c.$35m share buyback programme

 

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, announces that, further to the announcement on 5 March 2026, it has completed the sale of its pharmaceutical manufacturing business to Associated British Foods ("ABF") (the "Transaction").

Under the terms of the Transaction, the business was sold for an enterprise value of €34.3m (equivalent to c.$39.8m1), with net cash proceeds after transaction costs of approximately €30m (equivalent to c.$35m1).

The Transaction supports the Group's strategic objectives, repositioning Elementis as a pure-play specialty chemicals leader focused on value-added specialty additives in the Personal Care and Coatings markets. The Transaction improves adjusted operating margin2 for both the Group and the Personal Care division, and will reduce future capital intensity.

In recognition of Elementis's robust balance sheet, strong first quarter performance and unchanged outlook for the year, as set out in the trading update on 29 April 2026, the Board is pleased to announce that it will be returning the c.$35m net cash proceeds from the Transaction to shareholders by way of a share buyback programme. This is expected to commence as soon as practicable.

 

Luc van Ravenstein, CEO of Elementis, said:

 

"We are pleased to have completed the sale of the pharmaceutical manufacturing business. The Transaction further strengthens the quality of our portfolio and sharpens our focus on our core markets. We are excited about the opportunities ahead and the positive momentum behind our Elevate Elementis strategy.

ABF is the right home for the business, providing a global pharmaceutical platform and established customer relationships to support its continued growth. I would like to thank our colleagues from the pharmaceutical manufacturing business for their contribution to Elementis and wish them all the best for the future."

 

 

Enquiries

Investors:

Zeeshan Maqbool, Elementis plc

Tel: +44 (0) 7553 340 380

Press:

 Martin Robinson, Giles Kernick, Teneo

Tel: +44 (0) 20 7353 4200

 

 

Notes

 

1.    

Converted at the exchange rate of €1 = $1.1630.

2.    

Group and Personal Care adjusted operating margin will improve by 56 bps and 374 bps respectively, based on the Group's reported financial results for the year ended 31 December 2025, with  pro-forma Group revenue of $562.4m, Group adjusted operating profit of $122.4m, Personal Care revenue of $189.4m and adjusted operating profit of $68.5m.

 

About Elementis

Elementis is a global specialty chemicals company listed on the London Stock Exchange. The Group employs c.1,000 across 18 global locations. As recognised innovation leaders with deep expertise in rheology (the science of flow), and formulation solutions, we develop distinctive solutions and products to improve performance, achieve smoother production, and enhance sustainability credentials for customers across a range of industries. The Group also owns and operates one of the largest known commercial high-quality hectorite mines in the world. Hectorite is a special, high-purity clay mineral rich in magnesium and lithium, known for its ability to control viscosity, stabilise formulations, and deliver smooth, consistent textures that make it ideal for clean-label, high-performance formulations. 

Elementis is composed of two focused, high-margin businesses: Personal Care and Coatings. The Personal Care business manufactures natural and synthetic rheology modifiers to deliver premium product performance for personal care applications in skin care and cosmetics, as well as active ingredients for antiperspirants. Within Coatings, Elementis develops and manufactures rheology modifiers and premium performance additives for decorative and industrial paints and coatings. The Coatings business also includes our Energy and Adhesives, Sealants and Construction additives businesses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCAKDBDOBKDFAK
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not registered in any category of registration under the securities legislation of any province or territory of Canada. Nothing in this record constitutes "advice" concerning investing in, buying, or selling a security within the meaning of applicable Canadian securities legislation. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after obtaining advice from a registrant authorised under the securities legislation of your province or territory.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship is for news distribution and media services only and does not determine, influence, or shape the editorial content produced.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

Director/PDMR Shareholding

3 days, 5 hours ago

Transaction in Own Shares

3 days, 8 hours ago

Transaction in Own Shares

1 week, 3 days ago

Innovation Day

2 weeks, 2 days ago

Director/PDMR Shareholding

2 weeks, 3 days ago

Transaction in Own Shares

2 weeks, 3 days ago

Director/PDMR Shareholding

2 weeks, 3 days ago

Third Quarter Trading Update

3 weeks, 1 day ago

4 min read